NextPoint Therapeutics
Cambridge, United States· Est.
NextPoint Therapeutics focuses on novel immunotherapy targets for cancer, particularly in the HHLA2 pathway.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $122.5M
About
NextPoint Therapeutics focuses on novel immunotherapy targets for cancer, particularly in the HHLA2 pathway.
OncologyImmunology
Funding History
2Total raised:$122.5M
Series B$42.5M
Series B$80M